Stroke News

Patients with atrial fibrillation who underwent catheter ablation may have a lower risk for dementia compared with those treated with medical therapy, researchers found in a retrospective analysis.

Acute CVD events in a Southern California cohort were 1.62 times higher in the 2 days after the 2016 U.S. presidential election compared with the same 2 days the week before the election, researchers reported.

The European Society of Cardiology Congress was, for the first time, held virtually. From Aug. 29 to Sept. 1, the digital experience drew virtual attendees from around the world, to watch and hear the latest on topics ranging from the benefits of SGLT2 inhibition in patients without diabetes to the first randomized trial on the question of whether to stop ACE inhibitors and angiotensin receptor blockers in patients with COVID-19.

Cardiovascular and hematological risk factors increased the risk for in-hospital mortality by 613% and 336%, respectively, in pediatric patients who had an ischemic stroke.

Patients with a spouse who was admitted to the ICU may have increased risk for CV events in the few weeks after ICU admission, researchers found.

Supplementation with eicosapentaenoic acid and docosahexaenoic acid may reduce the risk for some CVD outcomes, including fatal MI and CHD events, researchers found.

Disparities in CVD prevalence substantially increased from 1999 to 2016 between patients with high resources and low resources, with the highest-resources group having a lower CVD rate compared with other groups, researchers found.

Artificial intelligence continues to affect cardiology with improved capabilities to diagnose certain conditions such as atrial fibrillation, and research is underway to learn more about its use in disease management, a presenter said.

Women who reported two or more moderate to severe menopause symptoms had increased risks for cardiovascular disease and stroke, but vasomotor symptom severity did not affect risk, according to data from the WHI Calcium and Vitamin D trial.

A longitudinal analysis of more than 72,000 patients who survived a first-time intracerebral hemorrhage identified infection as the leading cause of death in these patients over a 4-year period, according to findings published in Neurology.